Cover Image

The importance of the quadrivalent HPV vaccine in the elimination of cervical cancer in Brazil

Saved in:

Bibliographic Details
Main Authors:	Cecília Martins Roteli-Martins (Author), Ana Goretti Kalume Maranhão (Author), Susana Cristina Aidé Viviani Fialho (Author), Agnaldo Lopes da Silva-Filho (Author)
Format:	Book
Published:	Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Call to Eliminate Cervical Cancer in the Next Decade with a Focus on Brazil
by: Walquíria Quida Salles Pereira Primo, et al.
Published: (2021)

The path to elimination: FEBRASGO 2023's targeted strategies against cervical cancer in Brazil
by: Agnaldo Lopes da Silva Filho, et al.
Published: (2024)

Prevalência das Neoplasias Intra-epiteliais Cervicais e Lesões Induzidas pelo HPV nas Mulheres Soropositivas/AIDS
by: Susana Cristina Aidé Viviani Fialho
Published: (2002)

Respiratory syncytial virus: impact of the disease and preventive strategies in pregnant women and older adults: Number 6 - 2024
by: Cecília Maria Roteli-Martins, et al.
Published: (2024)

Vaccination in pregnant and postpartum women
by: Giuliane Jesus Lajos, et al.
Published: (2021)

National Vaccination Coverage Survey and its importance amid the challenges
by: Márcia de Cantuária Tauil, et al.
Published: (2024)

HPV Vaccines: Separating Myths from Reality
by: Julio César Teixeira, et al.
Published: (2019)

Prevalência do HPV em mulheres rastreadas para o câncer cervical Prevalence of genital HPV infection among women screened for cervical cancer
by: Cristina Helena Rama, et al.
Published: (2008)

HPV Vaccination and Screening with High-Performance Test: Brazilian Evidence
by: Julio Cesar Teixeira, et al.
Published: (2022)

Human papillomavirus vaccination for adult women
by: Cecília Maria Roteli-Martins, et al.
Published: (2022)

Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine
by: Neerja Bhatla, et al.
Published: (2023)

The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis
by: Anita Lukács, et al.
Published: (2020)

GARDASIL. QUADRIVALENT RECOMBINANT VACCINE AGAINST HPV (6, 11, 16, 18 TYPES)
by: article editorial
Published: (2007)

GARDASIL. QUADRIVALENT RECOMBINANT VACCINE AGAINST HPV (6, 11, 16, 18 TYPES)
by: article editorial
Published: (2007)

Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials
by: Stephen E. Goldstone
Published: (2023)

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years
by: Ivette Maldonado, et al.
Published: (2022)

Avaliação de métodos alternativos à citologia no rastreamento de lesões cervicais: detecção de DNA-HPV e inspeção visual Evaluation of alternative methods in cervical screening: HPV DNA detection and visual inspection
by: Renata Clementino Gontijo, et al.
Published: (2004)

Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
by: Luiz Carlos Zeferino, et al.
Published: (2018)

Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
by: Mojgan Karimi-Zarchi, et al.
Published: (2020)

Role of HPV 16 variants among cervical carcinoma samples from Northeastern Brazil
by: Rodrigo Lopes da Silva, et al.
Published: (2020)

FIRST APPLICATION EXPERIENCE OF THE QUADRIVALENT VACCINE FOR PREVENTION OF THE PAPILLOMA VIRAL INFECTION AND CERVICAL CANCER
by: M.G. Galitskaya, et al.
Published: (2008)

FIRST APPLICATION EXPERIENCE OF THE QUADRIVALENT VACCINE FOR PREVENTION OF THE PAPILLOMA VIRAL INFECTION AND CERVICAL CANCER
by: M.G. Galitskaya, et al.
Published: (2008)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
by: Samba O. Sow, et al.
Published: (2023)

HPV-associated cervicitis
by: Margarita V. Andreeva, et al.
Published: (2023)

Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials
by: Chantal Sauvageau, et al.
Published: (2020)

The effect of history of abnormal pap smear or preceding HPV infection on the humoral immune response to Quadrivalent Human Papilloma virus (qHPV) vaccine in women with systemic lupus erythematosus
by: J. Patricia Dhar, et al.
Published: (2018)

Cost-effectiveness for high dose quadrivalent versus the adjuvanted quadrivalent influenza vaccine in the Italian older adult population
by: Filippo Rumi, et al.
Published: (2023)

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age
by: E. D. Moreira, et al.
Published: (2018)

Emprego dos marcadores de prognóstico no tratamento para o carcinoma invasor de colo Use of the prognosis markers in the treatment for the invasive cervical carcinoma
by: Agnaldo Lopes Silva Filho
Published: (2009)

Evidence for the path to cervical cancer elimination
by: Afsan Bhadelia
Published: (2020)

Journey of the elimination of cervical cancer in China
by: Lihui Wei, et al.
Published: (2024)

Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countriesSearch strategy and selection criteria
by: Sok King Ong, et al.
Published: (2023)

Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine
by: Maria Lina Diaz
Published: (2009)

Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model
by: Pascal Crépey, et al.
Published: (2020)

Correlation between HPV-negative cervical lesions and cervical microenvironment
by: Jing-Jing Zheng, et al.
Published: (2020)

Comparison of HPV testing and cervical cytology in prevention of cervical cancer
by: Klaudia Remjasz, et al.
Published: (2022)

Comparison of HPV testing and cervical cytology in prevention of cervical cancer
by: Klaudia Remjasz, et al.
Published: (2022)

Quadrivalent inactivated influenza vaccine (VaxigripTetra™)
by: Viviane Gresset-Bourgeois, et al.
Published: (2018)

Eliminating HPV DNA Positive Result with Large Loop Excision of the Transformation Zone (LLETZ)/Loop Electrosurgical Excision Procedure (LEEP) in Precancerous Cervical Lesions
by: Rizal Sanif, et al.
Published: (2024)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
by: Brandon Wen Bing Chua, et al.
Published: (2022)